Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2017 - 2024)

Solid Biosciences' Depreciation & Amortization (CF) history spans 8 years, with the latest figure at $488000.0 for Q4 2024.

  • For Q4 2024, Depreciation & Amortization (CF) fell 16.87% year-over-year to $488000.0; the TTM value through Dec 2024 reached $2.5 million, down 4.88%, while the annual FY2024 figure was $2.5 million, 4.88% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2024 was $488000.0 at Solid Biosciences, up from $405000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.3 million in Q2 2020 and bottomed at $327000.0 in Q1 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $713500.0 (2021), against an average of $716500.0.
  • The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 102.74% in 2020 before it plummeted 53.49% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $796000.0 in 2020, then dropped by 4.52% to $760000.0 in 2021, then fell by 29.08% to $539000.0 in 2022, then rose by 8.91% to $587000.0 in 2023, then decreased by 16.87% to $488000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Depreciation & Amortization (CF) are $488000.0 (Q4 2024), $405000.0 (Q3 2024), and $1.2 million (Q2 2024).